iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 23,081 shares, a decline of 55.2% from the August 31st total of 51,524 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average trading volume of 151,159 shares, the short-interest ratio is currently 0.2 days.
Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF
A hedge fund recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Anchor Investment Management LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 2,898 shares of the company’s stock, valued at approximately $98,000.
iShares Genomics Immunology and Healthcare ETF Stock Performance
Shares of IDNA traded up $0.02 during trading hours on Monday, hitting $41.79. 126,035 shares of the stock were exchanged, compared to its average volume of 58,850. The stock’s 50-day moving average price is $37.12 and its two-hundred day moving average price is $32.72. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $22.76 and a 12-month high of $42.03. The company has a market cap of $284.17 million, a price-to-earnings ratio of 14.76 and a beta of 0.95.
iShares Genomics Immunology and Healthcare ETF Company Profile
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
